CPK served as a specialist to Relypsa, Inc., Sanofi-Aventis U.S. observed even in serum potassium ranges that are often not considered targets for therapeutic interventions. The heightened risk of mortality associated with hyperkalemia is present in all individual populations, even those in whom hyperkalemia occurs normally rarely, such as individuals with normal kidney function. 2014;10:653C662.8 […]